Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Scott Cenci as Senior Vice President, Chief Information and Data Officer. In this role, Scott...
Institutional Conviction Capital with No Warrants or Protections SignalsLong-Term Bet on Rezolve’s High-ROI Growth Path Fresh Funding Follows Major 2025 Milestones Including $70M ARR,Tier-1 Retail...
Emergency communications leader posts 477% YoY growth of APEX ARR; new funding to fuel cloud-native AI innovation, global expansion. Carbyne, the leading provider of cloud-native emergency...
On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), announced a strategic collaboration to...
OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today issued a strategic update regarding its recently announced Term Sheet with...
BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai presented the latest findings on lecanemab (Leqembi®) at the Alzheimer’s Association International Conference (AAIC), held in Toronto, July 27 to...
Ultromics, a pioneer in AI-driven cardiology solutions, today announced it has raised $55 million in Series C financing. The round was co-led by L&G, Allegis Capital and...
dbt Labs, the leader in standards for AI-ready structured data, today announced it has signed a strategic collaboration agreement (SCA) with Amazon Web Services (AWS)....
Caspian secures a U.S. customs broker license & drawback ABI and unveils its flagship duty drawback product to help exporters reclaim billions in unclaimed duty...
Nebulock, the AI-driven threat hunting platform transforming endpoint security, today announced it has raised $8.5 million in funding, including $6 million in seed funding led...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. ACCEPTPrivacy Policy
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.